Thursday, 23 January 2014

BioLargo Successfully Concludes Proof of Concept and Progresses to Pilot Phase for Its Oil Sands Decontamination Project with University of Alberta - Pilot to optimize for AOS Filter technology scalability and commercial application –

SANTA ANA, CA—(Jan. 21, 2014) - BioLargo, Inc. (OTCQB: BLGO) together with the University of Alberta has advanced its patented “advanced oxidation system” (AOS) filter to its pilot phase. The pilot follows the successful conclusion of the proof of concept and is targeted to begin in April 2014 to further develop, scale, test and commercialize the technology for use in the Athabasca Oil Sands. A key strategic initiative for the University in its efforts to develop and advance economically viable solutions for the environmental sustainability of the Canadian resources, the pilot will propel the technology from the lab into the field.

Proof of Concept Demonstration  
University of Alberta and BioLargo demonstrated in its proof of concept testing that the AOS Filter can
·       Rapidly dismantle difficult soluble containments;
·       Operate as a continual free flowing system;
·       Function with very low power consumption; and
·       Compete at a fraction of the cost of other technologies.

Dennis Calvert, BioLargo's president, stated: "BioLargo’s AOS Filter has been shown to reduce total acid-extractable organics in water at a rate never before demonstrated commercially. Based on proof of claim there is a belief BioLargo may have the lowest cost sustainable solution for the oil sands process-affected water. Having tested our technology, the esteemed University of Alberta is entering the AOS Filter industrial pilot-scale-testing phase, which we expect to confirm its commercial viability to treat oil sands tailings ponds and then eliminate the need for them on a go forward basis. Oil sands are commonly considered one of the most difficult water contamination situations. As such, this pilot project is expected to provide the groundwork for additional water treatment applications, including refining, fracking, remediation, agriculture and industrial waste among others."

Government Funding Established for Athabasca Oil Sands Solution  
Canada’s Athabasca Oil Sands is the second largest oil reserve in the world. The contaminated water in holding ponds has already reached one billion cubic meters and produces an additional 177 million cubic meters annually, with production expected to double by 2020. To address the situation’s special challenges, including large scale, the Alberta government has established a CDN$3.5B superfund for a solution, which includes the contaminated water issue.

Dr. Mohamed Gamal El-Din PhD, P.Eng, 45, of University of Alberta will lead the pilot study. He is internationally recognized for his fundamental and applied research in the area of water and wastewater treatment, Dr. Gamal El-Din’s work has resulted in important advancements in the area of advanced oxidation treatment and reactor design for fast-reaction environments, particularly, the application of ozone treatment as an advanced oxidation process.

Agreement in Principle
The basic terms of the business arrangements relating to the pilot project have been agreed in principle. All intellectual properties resulting from the project will be accrued and owned by BioLargo, Inc. The University of Alberta will receive a 5% royalty payment on all revenues generated with the remainder retained by BioLargo, Inc. Through its subsidiary, BioLargo Water Inc., the company has pledged to fund $1.6 million over four years in support of the project. In return, the University of Alberta has begun applying for government grants expected to exceed CDN $3.5 million, which will be announced as they are awarded. We expect a formal research contract will be executed between BioLargo and the University in the coming months as the funding commitments are finalized.

About BioLargo, Inc.
BioLargo, Inc. (OTCQB: BLGO) makes life better by delivering technology-based products that help solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at The subsidiary BioLargo Water, Inc. ( showcases the Advanced Oxidation Systems, including its AOS Filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project. The subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature's Best Solution® and Deodorall® brands. ( The subsidiary Clyra Medical Technologies, Inc. (, focuses on advanced wound care management and is preparing to make FDA 510(k) applications in 2014.

Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2012.

Investor Contact:
LHA - Becky Herrick and and Kirsten Chapman

Company contact:
Dennis Calvert, President
BioLargo, Inc.
949-643-9540 x1 

Tuesday, 14 January 2014

Letter to Shareholders: BioLargo Engages LHA for Investor Relations Services

Dear Shareholder, 

As I write to you today, we are more excited than ever about the opportunities before us as we leverage our technology in multiple growth markets. As such, we feel now is the time to build our presence within the investment community and educate Wall Street about the compelling investment opportunity BioLargo represents. Therefore, we have retained LHA as investor relations counsel to support our growth initiatives. LHA, formerly known as Lippert/Heilshorn & Associates, Inc., is a full-service investor relations agency with offices in New York City, San Francisco, Los Angeles and Tel Aviv. 

LHA will assist BioLargo in implementing a strategic investor relations program aimed at enhancing our presence on Wall Street as well as overseeing our capital markets activities. 

If you wish to contact LHA directly, your primary contact is Becky Herrick at 415.433.3777 or 

We are committed to providing our shareholders with quality communications and transparency, and our partnership with LHA demonstrates just that. We look forward to a promising 2014, and we appreciate your continued support of BioLargo. 

Warmest Regards, 


Dennis Calvert 
President & CEO 
Symbol: BLGO.OB